iShares Biotechnology ETF (IBB)
Summary
IBB Chart
People also search for
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001.
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.
iShares Biotechnology ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 1,735 | $292,867.05 | $322,553.85 | $29,686.8 | 10.14% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 609 | $79,352.7 | $113,523.69 | $34,170.99 | 43.06% |
 Stonebridge Capital Management Stonebridge Capital Management Inc. | 4,455 | $847,296 | $899,598.15 | $52,302.15 | 6.17% |
 Curtis Ellergodt Rothschild Investment LLC | 4,400 | $626,950.06 | $849,068 | $222,117.94 | 35.43% |
 Tom McDonald Richards, MERRILL & PETERSON Inc. | 75 | $9,593 | $13,980.75 | $4,387.75 | 45.74% |
iShares Biotechnology ETF (IBB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has iShares Biotechnology ETF ever had a stock split?
iShares Biotechnology ETF Profile
| NASDAQ (NMS) Exchange | US Country |
Overview
The described company operates as an investment fund focused on tracking the performance of a specific underlying index. By investing at least 80% of its assets in the securities that comprise the index, the fund aims to mimic the index's returns and behavior closely. This strategy indicates a focus on providing investors with exposure to the components of a particular market or sector through the index it follows. However, it is noteworthy that the fund is characterized as non-diverse, which means it may concentrate its investments in a particular sector, company, or geographical area, potentially increasing the risk of volatility and loss due to lack of diversification.
Products and Services
The fund offers a targeted investment product that primarily focuses on securities from its underlying index, alongside additional financial instruments to potentially enhance returns and manage risks:
- Component Securities Investments: The core of the fund's portfolio comprises at least 80% investment in the securities that are part of the underlying index it tracks. This approach is designed to replicate the performance of the index, offering investors exposure to its specified market or sector.
- Futures, Options, and Swap Contracts: Up to 20% of the fund's assets may be allocated to futures, options, and swap contracts. These derivative financial instruments can serve multiple purposes, including hedging against market volatility, leveraging to amplify returns, and speculative investment opportunities, allowing the fund to potentially enhance its overall performance.
- Cash and Cash Equivalents: A portion of the fund's assets may be held in cash or cash equivalents. This allocation is strategic, enabling the fund to manage liquidity effectively, meet redemption requests promptly, and take advantage of new investment opportunities as they arise. Holding cash and cash equivalents can also provide a buffer against market downturns.
